[Bullous pemphigoid in an infant]

Beatriz Sousa1, Alberto Mota, Helder Morgado

  • 1Serviço de Pediatria, Hospital de S. João, Faculdade de Medicina, Porto.

Acta Medica Portuguesa
|October 7, 2005
PubMed

Insights

Bullous pemphigoid, a rare autoimmune blistering disease, was diagnosed in a six-month-old infant. Treatment with corticosteroids led to a favorable outcome in this exceptional pediatric case.

Area of Science:

  • Dermatology
  • Immunology
  • Pediatrics

Background:

  • Bullous pemphigoid is an acquired autoimmune blistering disease primarily affecting the elderly.
  • It is exceptionally rare in infants, with only ten cases previously documented in medical literature.

Observation:

  • A previously healthy six-month-old infant presented with a six-day history of erythematous, vesico-bullous cutaneous lesions.
  • Clinical presentation suggested an autoimmune blistering disorder.

Findings:

  • Histopathological examination and direct immunofluorescence studies confirmed the diagnosis of bullous pemphigoid.
  • The infant exhibited characteristic immunopathological findings of the disease.

Implications:

  • This case expands the limited literature on infantile bullous pemphigoid, highlighting its occurrence in very young children.
  • Successful treatment with systemic and topical corticosteroids demonstrates therapeutic efficacy in this pediatric demographic.
  • Further research into the specific triggers and long-term outcomes of infantile bullous pemphigoid is warranted.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...